 | • レポートコード：QY2112C03904 • 出版社/出版日：QYResearch / 2021年12月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥735,000 (USD4,900) | ▷ お問い合わせ |
| Multi User | ￥1,102,500 (USD7,350) | ▷ お問い合わせ |
| Enterprise License | ￥1,470,000 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査資料はペントバルビタールナトリウム注射の世界市場の現状について調査・分析し、2027年までの市場を予測しました。ペントバルビタールナトリウム注射の世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（1000mg / 20mL、2500mg / 50mL）、用途別市場規模（成人用、小児用）、主要地域別市場規模（北米・アメリカ、ヨーロッパ、アジア・日本・中国・インド、中南米、中東・アフリカ）、関連企業の情報、バリューチェーン・販売チャネル、市場動向などを収録しています。 ・ペントバルビタールナトリウム注射の世界市場概要 ・メーカー別の競争状況、市場シェア ・ペントバルビタールナトリウム注射の種類別市場規模：1000mg / 20mL、2500mg / 50mL ・ペントバルビタールナトリウム注射の用途別市場規模：成人用、小児用 ・北米のペントバルビタールナトリウム注射市場規模2016-2027：種類別、用途別、国別（アメリカ、カナダ） ・ヨーロッパのペントバルビタールナトリウム注射市場規模2016-2027：種類別、用途別、国別（ドイツ、フランス、イギリス） ・アジアのペントバルビタールナトリウム注射市場規模2016-2027：種類別、用途別、国別（日本、中国、インド、韓国） ・中南米のペントバルビタールナトリウム注射市場規模2016-2027：種類別、用途別、国別（メキシコ、ブラジル） ・中東・アフリカのペントバルビタールナトリウム注射市場規模2016-2027：種類別、用途別、国別（トルコ、サウジアラビア） ・企業情報：Leucadia Pharmaceuticals、SAGENT Pharmaceuticals、Martindale Pharma、Bioveta、Akorn Pharmaceuticals ・ペントバルビタールナトリウム注射のバリューチェーン・販売チャネル分析 ・ペントバルビタールナトリウム注射の世界市場動向 |
Pentobarbital Sodium Injection is a sterile solution for intravenous or intramuscular injection. Pentobarbital Sodium Injection is a short-acting barbiturate, chemically designated as sodium 5-ethyl-5-(1-methylbutyl) barbiturate. The barbiturates are nonselective central nervous system depressants which are primarily used as sedative hypnotics and also anticonvulsants in subhypnotic doses.
Market Analysis and Insights: Global Pentobarbital Sodium Injection Market
The global Pentobarbital Sodium Injection market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.
Global Pentobarbital Sodium Injection Scope and Segment
Pentobarbital Sodium Injection market is segmented by Dosage Form & Strength Type, and by Application. Players, stakeholders, and other participants in the global Pentobarbital Sodium Injection market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Dosage Form & Strength Type and by Application for the period 2016-2027.
Segment by Dosage Form & Strength Type
1000mg/20mL
2500mg/50mL
Segment by Application
Adult Use
Pediatric Use
By Company
Leucadia Pharmaceuticals
SAGENT Pharmaceuticals
Martindale Pharma
Bioveta
Akorn Pharmaceuticals
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 Pentobarbital Sodium Injection Product Introduction
1.2 Market by Dosage Form & Strength Type
1.2.1 Global Pentobarbital Sodium Injection Market Size Growth Rate by Dosage Form & Strength Type
1.2.2 1000mg/20mL
1.2.3 2500mg/50mL
1.3 Market by Application
1.3.1 Global Pentobarbital Sodium Injection Market Size Growth Rate by Application
1.3.2 Adult Use
1.3.3 Pediatric Use
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Pentobarbital Sodium Injection Sales Estimates and Forecasts 2016-2027
2.2 Global Pentobarbital Sodium Injection Revenue Estimates and Forecasts 2016-2027
2.3 Global Pentobarbital Sodium Injection Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Pentobarbital Sodium Injection Regions by Sales
2.4.1 Global Top Pentobarbital Sodium Injection Regions by Sales (2016-2021)
2.4.2 Global Top Pentobarbital Sodium Injection Regions by Sales (2022-2027)
2.5 Global Top Pentobarbital Sodium Injection Regions by Revenue
2.5.1 Global Top Pentobarbital Sodium Injection Regions by Revenue (2016-2021)
2.5.2 Global Top Pentobarbital Sodium Injection Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Pentobarbital Sodium Injection Sales by Manufacturers
3.1.1 Global Top Pentobarbital Sodium Injection Manufacturers by Sales (2016-2021)
3.1.2 Global Top Pentobarbital Sodium Injection Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Pentobarbital Sodium Injection Sales in 2020
3.2 Global Pentobarbital Sodium Injection Revenue by Manufacturers
3.2.1 Global Top Pentobarbital Sodium Injection Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Pentobarbital Sodium Injection Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Pentobarbital Sodium Injection Revenue in 2020
3.3 Global Pentobarbital Sodium Injection Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Pentobarbital Sodium Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Pentobarbital Sodium Injection Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Pentobarbital Sodium Injection Sales by Dosage Form & Strength Type
4.1.1 Global Pentobarbital Sodium Injection Historical Sales by Dosage Form & Strength Type (2016-2021)
4.1.2 Global Pentobarbital Sodium Injection Forecasted Sales by Dosage Form & Strength Type (2022-2027)
4.1.3 Global Pentobarbital Sodium Injection Sales Market Share by Dosage Form & Strength Type (2016-2027)
4.2 Global Pentobarbital Sodium Injection Revenue by Dosage Form & Strength Type
4.2.1 Global Pentobarbital Sodium Injection Historical Revenue by Dosage Form & Strength Type (2016-2021)
4.2.2 Global Pentobarbital Sodium Injection Forecasted Revenue by Dosage Form & Strength Type (2022-2027)
4.2.3 Global Pentobarbital Sodium Injection Revenue Market Share by Dosage Form & Strength Type (2016-2027)
4.3 Global Pentobarbital Sodium Injection Price by Dosage Form & Strength Type
4.3.1 Global Pentobarbital Sodium Injection Price by Dosage Form & Strength Type (2016-2021)
4.3.2 Global Pentobarbital Sodium Injection Price Forecast by Dosage Form & Strength Type (2022-2027)
5 Market Size by Application
5.1 Global Pentobarbital Sodium Injection Sales by Application
5.1.1 Global Pentobarbital Sodium Injection Historical Sales by Application (2016-2021)
5.1.2 Global Pentobarbital Sodium Injection Forecasted Sales by Application (2022-2027)
5.1.3 Global Pentobarbital Sodium Injection Sales Market Share by Application (2016-2027)
5.2 Global Pentobarbital Sodium Injection Revenue by Application
5.2.1 Global Pentobarbital Sodium Injection Historical Revenue by Application (2016-2021)
5.2.2 Global Pentobarbital Sodium Injection Forecasted Revenue by Application (2022-2027)
5.2.3 Global Pentobarbital Sodium Injection Revenue Market Share by Application (2016-2027)
5.3 Global Pentobarbital Sodium Injection Price by Application
5.3.1 Global Pentobarbital Sodium Injection Price by Application (2016-2021)
5.3.2 Global Pentobarbital Sodium Injection Price Forecast by Application (2022-2027)
6 North America
6.1 North America Pentobarbital Sodium Injection Market Size by Dosage Form & Strength Type
6.1.1 North America Pentobarbital Sodium Injection Sales by Dosage Form & Strength Type (2016-2027)
6.1.2 North America Pentobarbital Sodium Injection Revenue by Dosage Form & Strength Type (2016-2027)
6.2 North America Pentobarbital Sodium Injection Market Size by Application
6.2.1 North America Pentobarbital Sodium Injection Sales by Application (2016-2027)
6.2.2 North America Pentobarbital Sodium Injection Revenue by Application (2016-2027)
6.3 North America Pentobarbital Sodium Injection Market Size by Country
6.3.1 North America Pentobarbital Sodium Injection Sales by Country (2016-2027)
6.3.2 North America Pentobarbital Sodium Injection Revenue by Country (2016-2027)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Pentobarbital Sodium Injection Market Size by Dosage Form & Strength Type
7.1.1 Europe Pentobarbital Sodium Injection Sales by Dosage Form & Strength Type (2016-2027)
7.1.2 Europe Pentobarbital Sodium Injection Revenue by Dosage Form & Strength Type (2016-2027)
7.2 Europe Pentobarbital Sodium Injection Market Size by Application
7.2.1 Europe Pentobarbital Sodium Injection Sales by Application (2016-2027)
7.2.2 Europe Pentobarbital Sodium Injection Revenue by Application (2016-2027)
7.3 Europe Pentobarbital Sodium Injection Market Size by Country
7.3.1 Europe Pentobarbital Sodium Injection Sales by Country (2016-2027)
7.3.2 Europe Pentobarbital Sodium Injection Revenue by Country (2016-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Pentobarbital Sodium Injection Market Size by Dosage Form & Strength Type
8.1.1 Asia Pacific Pentobarbital Sodium Injection Sales by Dosage Form & Strength Type (2016-2027)
8.1.2 Asia Pacific Pentobarbital Sodium Injection Revenue by Dosage Form & Strength Type (2016-2027)
8.2 Asia Pacific Pentobarbital Sodium Injection Market Size by Application
8.2.1 Asia Pacific Pentobarbital Sodium Injection Sales by Application (2016-2027)
8.2.2 Asia Pacific Pentobarbital Sodium Injection Revenue by Application (2016-2027)
8.3 Asia Pacific Pentobarbital Sodium Injection Market Size by Region
8.3.1 Asia Pacific Pentobarbital Sodium Injection Sales by Region (2016-2027)
8.3.2 Asia Pacific Pentobarbital Sodium Injection Revenue by Region (2016-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Pentobarbital Sodium Injection Market Size by Dosage Form & Strength Type
9.1.1 Latin America Pentobarbital Sodium Injection Sales by Dosage Form & Strength Type (2016-2027)
9.1.2 Latin America Pentobarbital Sodium Injection Revenue by Dosage Form & Strength Type (2016-2027)
9.2 Latin America Pentobarbital Sodium Injection Market Size by Application
9.2.1 Latin America Pentobarbital Sodium Injection Sales by Application (2016-2027)
9.2.2 Latin America Pentobarbital Sodium Injection Revenue by Application (2016-2027)
9.3 Latin America Pentobarbital Sodium Injection Market Size by Country
9.3.1 Latin America Pentobarbital Sodium Injection Sales by Country (2016-2027)
9.3.2 Latin America Pentobarbital Sodium Injection Revenue by Country (2016-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Pentobarbital Sodium Injection Market Size by Dosage Form & Strength Type
10.1.1 Middle East and Africa Pentobarbital Sodium Injection Sales by Dosage Form & Strength Type (2016-2027)
10.1.2 Middle East and Africa Pentobarbital Sodium Injection Revenue by Dosage Form & Strength Type (2016-2027)
10.2 Middle East and Africa Pentobarbital Sodium Injection Market Size by Application
10.2.1 Middle East and Africa Pentobarbital Sodium Injection Sales by Application (2016-2027)
10.2.2 Middle East and Africa Pentobarbital Sodium Injection Revenue by Application (2016-2027)
10.3 Middle East and Africa Pentobarbital Sodium Injection Market Size by Country
10.3.1 Middle East and Africa Pentobarbital Sodium Injection Sales by Country (2016-2027)
10.3.2 Middle East and Africa Pentobarbital Sodium Injection Revenue by Country (2016-2027)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Leucadia Pharmaceuticals
11.1.1 Leucadia Pharmaceuticals Corporation Information
11.1.2 Leucadia Pharmaceuticals Overview
11.1.3 Leucadia Pharmaceuticals Pentobarbital Sodium Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Leucadia Pharmaceuticals Pentobarbital Sodium Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Leucadia Pharmaceuticals Recent Developments
11.2 SAGENT Pharmaceuticals
11.2.1 SAGENT Pharmaceuticals Corporation Information
11.2.2 SAGENT Pharmaceuticals Overview
11.2.3 SAGENT Pharmaceuticals Pentobarbital Sodium Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 SAGENT Pharmaceuticals Pentobarbital Sodium Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 SAGENT Pharmaceuticals Recent Developments
11.3 Martindale Pharma
11.3.1 Martindale Pharma Corporation Information
11.3.2 Martindale Pharma Overview
11.3.3 Martindale Pharma Pentobarbital Sodium Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Martindale Pharma Pentobarbital Sodium Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Martindale Pharma Recent Developments
11.4 Bioveta
11.4.1 Bioveta Corporation Information
11.4.2 Bioveta Overview
11.4.3 Bioveta Pentobarbital Sodium Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Bioveta Pentobarbital Sodium Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Bioveta Recent Developments
11.5 Akorn Pharmaceuticals
11.5.1 Akorn Pharmaceuticals Corporation Information
11.5.2 Akorn Pharmaceuticals Overview
11.5.3 Akorn Pharmaceuticals Pentobarbital Sodium Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 Akorn Pharmaceuticals Pentobarbital Sodium Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Akorn Pharmaceuticals Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Pentobarbital Sodium Injection Value Chain Analysis
12.2 Pentobarbital Sodium Injection Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Pentobarbital Sodium Injection Production Mode & Process
12.4 Pentobarbital Sodium Injection Sales and Marketing
12.4.1 Pentobarbital Sodium Injection Sales Channels
12.4.2 Pentobarbital Sodium Injection Distributors
12.5 Pentobarbital Sodium Injection Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Pentobarbital Sodium Injection Industry Trends
13.2 Pentobarbital Sodium Injection Market Drivers
13.3 Pentobarbital Sodium Injection Market Challenges
13.4 Pentobarbital Sodium Injection Market Restraints
14 Key Findings in The Global Pentobarbital Sodium Injection Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Table 1. Global Pentobarbital Sodium Injection Market Size Growth Rate by Dosage Form & Strength Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of 1000mg/20mL
Table 3. Major Manufacturers of 2500mg/50mL
Table 4. Global Pentobarbital Sodium Injection Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 5. Global Pentobarbital Sodium Injection Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 6. Global Pentobarbital Sodium Injection Sales by Region (2016-2021) & (KL)
Table 7. Global Pentobarbital Sodium Injection Sales Market Share by Region (2016-2021)
Table 8. Global Pentobarbital Sodium Injection Sales by Region (2022-2027) & (KL)
Table 9. Global Pentobarbital Sodium Injection Sales Market Share by Region (2022-2027)
Table 10. Global Pentobarbital Sodium Injection Revenue by Region (2016-2021) & (US$ Million)
Table 11. Global Pentobarbital Sodium Injection Revenue Market Share by Region (2016-2021)
Table 12. Global Pentobarbital Sodium Injection Revenue by Region (2022-2027) & (US$ Million)
Table 13. Global Pentobarbital Sodium Injection Revenue Market Share by Region (2022-2027)
Table 14. Global Pentobarbital Sodium Injection Sales by Manufacturers (2016-2021) & (KL)
Table 15. Global Pentobarbital Sodium Injection Sales Share by Manufacturers (2016-2021)
Table 16. Global Pentobarbital Sodium Injection Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 17. Global Pentobarbital Sodium Injection Revenue Share by Manufacturers (2016-2021)
Table 18. Pentobarbital Sodium Injection Price by Manufacturers 2016-2021 (US$/L)
Table 19. Global Pentobarbital Sodium Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Pentobarbital Sodium Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pentobarbital Sodium Injection as of 2020)
Table 21. Pentobarbital Sodium Injection Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Pentobarbital Sodium Injection Product Offered
Table 23. Date of Manufacturers Enter into Pentobarbital Sodium Injection Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Pentobarbital Sodium Injection Sales by Dosage Form & Strength Type (2016-2021) & (KL)
Table 26. Global Pentobarbital Sodium Injection Sales by Dosage Form & Strength Type (2022-2027) & (KL)
Table 27. Global Pentobarbital Sodium Injection Sales Share by Dosage Form & Strength Type (2016-2021)
Table 28. Global Pentobarbital Sodium Injection Sales Share by Dosage Form & Strength Type (2022-2027)
Table 29. Global Pentobarbital Sodium Injection Revenue by Dosage Form & Strength Type (2016-2021) & (US$ Million)
Table 30. Global Pentobarbital Sodium Injection Revenue by Dosage Form & Strength Type (2022-2027) & (US$ Million)
Table 31. Global Pentobarbital Sodium Injection Revenue Share by Dosage Form & Strength Type (2016-2021)
Table 32. Global Pentobarbital Sodium Injection Revenue Share by Dosage Form & Strength Type (2022-2027)
Table 33. Pentobarbital Sodium Injection Price by Dosage Form & Strength Type (2016-2021) & (US$/L)
Table 34. Global Pentobarbital Sodium Injection Price Forecast by Dosage Form & Strength Type (2022-2027) & (US$/L)
Table 35. Global Pentobarbital Sodium Injection Sales by Application (2016-2021) & (KL)
Table 36. Global Pentobarbital Sodium Injection Sales by Application (2022-2027) & (KL)
Table 37. Global Pentobarbital Sodium Injection Sales Share by Application (2016-2021)
Table 38. Global Pentobarbital Sodium Injection Sales Share by Application (2022-2027)
Table 39. Global Pentobarbital Sodium Injection Revenue by Application (2016-2021) & (US$ Million)
Table 40. Global Pentobarbital Sodium Injection Revenue by Application (2022-2027) & (US$ Million)
Table 41. Global Pentobarbital Sodium Injection Revenue Share by Application (2016-2021)
Table 42. Global Pentobarbital Sodium Injection Revenue Share by Application (2022-2027)
Table 43. Pentobarbital Sodium Injection Price by Application (2016-2021) & (US$/L)
Table 44. Global Pentobarbital Sodium Injection Price Forecast by Application (2022-2027) & (US$/L)
Table 45. North America Pentobarbital Sodium Injection Sales by Dosage Form & Strength Type (2016-2021) & (KL)
Table 46. North America Pentobarbital Sodium Injection Sales by Dosage Form & Strength Type (2022-2027) & (KL)
Table 47. North America Pentobarbital Sodium Injection Revenue by Dosage Form & Strength Type (2016-2021) & (US$ Million)
Table 48. North America Pentobarbital Sodium Injection Revenue by Dosage Form & Strength Type (2022-2027) & (US$ Million)
Table 49. North America Pentobarbital Sodium Injection Sales by Application (2016-2021) & (KL)
Table 50. North America Pentobarbital Sodium Injection Sales by Application (2022-2027) & (KL)
Table 51. North America Pentobarbital Sodium Injection Revenue by Application (2016-2021) & (US$ Million)
Table 52. North America Pentobarbital Sodium Injection Revenue by Application (2022-2027) & (US$ Million)
Table 53. North America Pentobarbital Sodium Injection Sales by Country (2016-2021) & (KL)
Table 54. North America Pentobarbital Sodium Injection Sales by Country (2022-2027) & (KL)
Table 55. North America Pentobarbital Sodium Injection Revenue by Country (2016-2021) & (US$ Million)
Table 56. North America Pentobarbital Sodium Injection Revenue by Country (2022-2027) & (US$ Million)
Table 57. Europe Pentobarbital Sodium Injection Sales by Dosage Form & Strength Type (2016-2021) & (KL)
Table 58. Europe Pentobarbital Sodium Injection Sales by Dosage Form & Strength Type (2022-2027) & (KL)
Table 59. Europe Pentobarbital Sodium Injection Revenue by Dosage Form & Strength Type (2016-2021) & (US$ Million)
Table 60. Europe Pentobarbital Sodium Injection Revenue by Dosage Form & Strength Type (2022-2027) & (US$ Million)
Table 61. Europe Pentobarbital Sodium Injection Sales by Application (2016-2021) & (KL)
Table 62. Europe Pentobarbital Sodium Injection Sales by Application (2022-2027) & (KL)
Table 63. Europe Pentobarbital Sodium Injection Revenue by Application (2016-2021) & (US$ Million)
Table 64. Europe Pentobarbital Sodium Injection Revenue by Application (2022-2027) & (US$ Million)
Table 65. Europe Pentobarbital Sodium Injection Sales by Country (2016-2021) & (KL)
Table 66. Europe Pentobarbital Sodium Injection Sales by Country (2022-2027) & (KL)
Table 67. Europe Pentobarbital Sodium Injection Revenue by Country (2016-2021) & (US$ Million)
Table 68. Europe Pentobarbital Sodium Injection Revenue by Country (2022-2027) & (US$ Million)
Table 69. Asia Pacific Pentobarbital Sodium Injection Sales by Dosage Form & Strength Type (2016-2021) & (KL)
Table 70. Asia Pacific Pentobarbital Sodium Injection Sales by Dosage Form & Strength Type (2022-2027) & (KL)
Table 71. Asia Pacific Pentobarbital Sodium Injection Revenue by Dosage Form & Strength Type (2016-2021) & (US$ Million)
Table 72. Asia Pacific Pentobarbital Sodium Injection Revenue by Dosage Form & Strength Type (2022-2027) & (US$ Million)
Table 73. Asia Pacific Pentobarbital Sodium Injection Sales by Application (2016-2021) & (KL)
Table 74. Asia Pacific Pentobarbital Sodium Injection Sales by Application (2022-2027) & (KL)
Table 75. Asia Pacific Pentobarbital Sodium Injection Revenue by Application (2016-2021) & (US$ Million)
Table 76. Asia Pacific Pentobarbital Sodium Injection Revenue by Application (2022-2027) & (US$ Million)
Table 77. Asia Pacific Pentobarbital Sodium Injection Sales by Region (2016-2021) & (KL)
Table 78. Asia Pacific Pentobarbital Sodium Injection Sales by Region (2022-2027) & (KL)
Table 79. Asia Pacific Pentobarbital Sodium Injection Revenue by Region (2016-2021) & (US$ Million)
Table 80. Asia Pacific Pentobarbital Sodium Injection Revenue by Region (2022-2027) & (US$ Million)
Table 81. Latin America Pentobarbital Sodium Injection Sales by Dosage Form & Strength Type (2016-2021) & (KL)
Table 82. Latin America Pentobarbital Sodium Injection Sales by Dosage Form & Strength Type (2022-2027) & (KL)
Table 83. Latin America Pentobarbital Sodium Injection Revenue by Dosage Form & Strength Type (2016-2021) & (US$ Million)
Table 84. Latin America Pentobarbital Sodium Injection Revenue by Dosage Form & Strength Type (2022-2027) & (US$ Million)
Table 85. Latin America Pentobarbital Sodium Injection Sales by Application (2016-2021) & (KL)
Table 86. Latin America Pentobarbital Sodium Injection Sales by Application (2022-2027) & (KL)
Table 87. Latin America Pentobarbital Sodium Injection Revenue by Application (2016-2021) & (US$ Million)
Table 88. Latin America Pentobarbital Sodium Injection Revenue by Application (2022-2027) & (US$ Million)
Table 89. Latin America Pentobarbital Sodium Injection Sales by Country (2016-2021) & (KL)
Table 90. Latin America Pentobarbital Sodium Injection Sales by Country (2022-2027) & (KL)
Table 91. Latin America Pentobarbital Sodium Injection Revenue by Country (2016-2021) & (US$ Million)
Table 92. Latin America Pentobarbital Sodium Injection Revenue by Country (2022-2027) & (US$ Million)
Table 93. Middle East and Africa Pentobarbital Sodium Injection Sales by Dosage Form & Strength Type (2016-2021) & (KL)
Table 94. Middle East and Africa Pentobarbital Sodium Injection Sales by Dosage Form & Strength Type (2022-2027) & (KL)
Table 95. Middle East and Africa Pentobarbital Sodium Injection Revenue by Dosage Form & Strength Type (2016-2021) & (US$ Million)
Table 96. Middle East and Africa Pentobarbital Sodium Injection Revenue by Dosage Form & Strength Type (2022-2027) & (US$ Million)
Table 97. Middle East and Africa Pentobarbital Sodium Injection Sales by Application (2016-2021) & (KL)
Table 98. Middle East and Africa Pentobarbital Sodium Injection Sales by Application (2022-2027) & (KL)
Table 99. Middle East and Africa Pentobarbital Sodium Injection Revenue by Application (2016-2021) & (US$ Million)
Table 100. Middle East and Africa Pentobarbital Sodium Injection Revenue by Application (2022-2027) & (US$ Million)
Table 101. Middle East and Africa Pentobarbital Sodium Injection Sales by Country (2016-2021) & (KL)
Table 102. Middle East and Africa Pentobarbital Sodium Injection Sales by Country (2022-2027) & (KL)
Table 103. Middle East and Africa Pentobarbital Sodium Injection Revenue by Country (2016-2021) & (US$ Million)
Table 104. Middle East and Africa Pentobarbital Sodium Injection Revenue by Country (2022-2027) & (US$ Million)
Table 105. Leucadia Pharmaceuticals Corporation Information
Table 106. Leucadia Pharmaceuticals Description and Major Businesses
Table 107. Leucadia Pharmaceuticals Pentobarbital Sodium Injection Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2016-2021)
Table 108. Leucadia Pharmaceuticals Pentobarbital Sodium Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Leucadia Pharmaceuticals Recent Developments
Table 110. SAGENT Pharmaceuticals Corporation Information
Table 111. SAGENT Pharmaceuticals Description and Major Businesses
Table 112. SAGENT Pharmaceuticals Pentobarbital Sodium Injection Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2016-2021)
Table 113. SAGENT Pharmaceuticals Pentobarbital Sodium Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. SAGENT Pharmaceuticals Recent Developments
Table 115. Martindale Pharma Corporation Information
Table 116. Martindale Pharma Description and Major Businesses
Table 117. Martindale Pharma Pentobarbital Sodium Injection Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2016-2021)
Table 118. Martindale Pharma Pentobarbital Sodium Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Martindale Pharma Recent Developments
Table 120. Bioveta Corporation Information
Table 121. Bioveta Description and Major Businesses
Table 122. Bioveta Pentobarbital Sodium Injection Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2016-2021)
Table 123. Bioveta Pentobarbital Sodium Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Bioveta Recent Developments
Table 125. Akorn Pharmaceuticals Corporation Information
Table 126. Akorn Pharmaceuticals Description and Major Businesses
Table 127. Akorn Pharmaceuticals Pentobarbital Sodium Injection Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2016-2021)
Table 128. Akorn Pharmaceuticals Pentobarbital Sodium Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Akorn Pharmaceuticals Recent Developments
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Pentobarbital Sodium Injection Distributors List
Table 133. Pentobarbital Sodium Injection Customers List
Table 134. Pentobarbital Sodium Injection Market Trends
Table 135. Pentobarbital Sodium Injection Market Drivers
Table 136. Pentobarbital Sodium Injection Market Challenges
Table 137. Pentobarbital Sodium Injection Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Pentobarbital Sodium Injection Product Picture
Figure 2. Global Pentobarbital Sodium Injection Market Share by Dosage Form & Strength Type in 2020 & 2027
Figure 3. 1000mg/20mL Product Picture
Figure 4. 2500mg/50mL Product Picture
Figure 5. Global Pentobarbital Sodium Injection Market Share by Application in 2020 & 2027
Figure 6. Adult Use
Figure 7. Pediatric Use
Figure 8. Pentobarbital Sodium Injection Report Years Considered
Figure 9. Global Pentobarbital Sodium Injection Sales 2016-2027 (KL)
Figure 10. Global Pentobarbital Sodium Injection Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Pentobarbital Sodium Injection Revenue 2016-2027 (US$ Million)
Figure 12. Global Pentobarbital Sodium Injection Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 13. Global Pentobarbital Sodium Injection Sales Market Share by Region (2016-2021)
Figure 14. Global Pentobarbital Sodium Injection Sales Market Share by Region (2022-2027)
Figure 15. North America Pentobarbital Sodium Injection Sales YoY (2016-2027) & (KL)
Figure 16. North America Pentobarbital Sodium Injection Revenue YoY (2016-2027) & (US$ Million)
Figure 17. Europe Pentobarbital Sodium Injection Sales YoY (2016-2027) & (KL)
Figure 18. Europe Pentobarbital Sodium Injection Revenue YoY (2016-2027) & (US$ Million)
Figure 19. Asia-Pacific Pentobarbital Sodium Injection Sales YoY (2016-2027) & (KL)
Figure 20. Asia-Pacific Pentobarbital Sodium Injection Revenue YoY (2016-2027) & (US$ Million)
Figure 21. Latin America Pentobarbital Sodium Injection Sales YoY (2016-2027) & (KL)
Figure 22. Latin America Pentobarbital Sodium Injection Revenue YoY (2016-2027) & (US$ Million)
Figure 23. Middle East & Africa Pentobarbital Sodium Injection Sales YoY (2016-2027) & (KL)
Figure 24. Middle East & Africa Pentobarbital Sodium Injection Revenue YoY (2016-2027) & (US$ Million)
Figure 25. The Top 10 and Top 5 Players Market Share by Pentobarbital Sodium Injection Sales in 2020
Figure 26. The Top 10 and Top 5 Players Market Share by Pentobarbital Sodium Injection Revenue in 2020
Figure 27. Pentobarbital Sodium Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 28. Global Pentobarbital Sodium Injection Sales Market Share by Dosage Form & Strength Type (2016-2027)
Figure 29. Global Pentobarbital Sodium Injection Revenue Market Share by Dosage Form & Strength Type (2016-2027)
Figure 30. Global Pentobarbital Sodium Injection Sales Market Share by Application (2016-2027)
Figure 31. Global Pentobarbital Sodium Injection Revenue Market Share by Application (2016-2027)
Figure 32. North America Pentobarbital Sodium Injection Sales Market Share by Dosage Form & Strength Type (2016-2027)
Figure 33. North America Pentobarbital Sodium Injection Revenue Market Share by Dosage Form & Strength Type (2016-2027)
Figure 34. North America Pentobarbital Sodium Injection Sales Market Share by Application (2016-2027)
Figure 35. North America Pentobarbital Sodium Injection Revenue Market Share by Application (2016-2027)
Figure 36. North America Pentobarbital Sodium Injection Sales Share by Country (2016-2027)
Figure 37. North America Pentobarbital Sodium Injection Revenue Share by Country (2016-2027)
Figure 38. United States Pentobarbital Sodium Injection Revenue (2016-2027) & (US$ Million)
Figure 39. Canada Pentobarbital Sodium Injection Revenue (2016-2027) & (US$ Million)
Figure 40. Europe Pentobarbital Sodium Injection Sales Market Share by Dosage Form & Strength Type (2016-2027)
Figure 41. Europe Pentobarbital Sodium Injection Revenue Market Share by Dosage Form & Strength Type (2016-2027)
Figure 42. Europe Pentobarbital Sodium Injection Sales Market Share by Application (2016-2027)
Figure 43. Europe Pentobarbital Sodium Injection Revenue Market Share by Application (2016-2027)
Figure 44. Europe Pentobarbital Sodium Injection Sales Share by Country (2016-2027)
Figure 45. Europe Pentobarbital Sodium Injection Revenue Share by Country (2016-2027)
Figure 46. Germany Pentobarbital Sodium Injection Revenue (2016-2027) & (US$ Million)
Figure 47. France Pentobarbital Sodium Injection Revenue (2016-2027) & (US$ Million)
Figure 48. U.K. Pentobarbital Sodium Injection Revenue (2016-2027) & (US$ Million)
Figure 49. Italy Pentobarbital Sodium Injection Revenue (2016-2027) & (US$ Million)
Figure 50. Russia Pentobarbital Sodium Injection Revenue (2016-2027) & (US$ Million)
Figure 51. Asia Pacific Pentobarbital Sodium Injection Sales Market Share by Dosage Form & Strength Type (2016-2027)
Figure 52. Asia Pacific Pentobarbital Sodium Injection Revenue Market Share by Dosage Form & Strength Type (2016-2027)
Figure 53. Asia Pacific Pentobarbital Sodium Injection Sales Market Share by Application (2016-2027)
Figure 54. Asia Pacific Pentobarbital Sodium Injection Revenue Market Share by Application (2016-2027)
Figure 55. Asia Pacific Pentobarbital Sodium Injection Sales Share by Region (2016-2027)
Figure 56. Asia Pacific Pentobarbital Sodium Injection Revenue Share by Region (2016-2027)
Figure 57. China Pentobarbital Sodium Injection Revenue (2016-2027) & (US$ Million)
Figure 58. Japan Pentobarbital Sodium Injection Revenue (2016-2027) & (US$ Million)
Figure 59. South Korea Pentobarbital Sodium Injection Revenue (2016-2027) & (US$ Million)
Figure 60. India Pentobarbital Sodium Injection Revenue (2016-2027) & (US$ Million)
Figure 61. Australia Pentobarbital Sodium Injection Revenue (2016-2027) & (US$ Million)
Figure 62. China Taiwan Pentobarbital Sodium Injection Revenue (2016-2027) & (US$ Million)
Figure 63. Indonesia Pentobarbital Sodium Injection Revenue (2016-2027) & (US$ Million)
Figure 64. Thailand Pentobarbital Sodium Injection Revenue (2016-2027) & (US$ Million)
Figure 65. Malaysia Pentobarbital Sodium Injection Revenue (2016-2027) & (US$ Million)
Figure 66. Latin America Pentobarbital Sodium Injection Sales Market Share by Dosage Form & Strength Type (2016-2027)
Figure 67. Latin America Pentobarbital Sodium Injection Revenue Market Share by Dosage Form & Strength Type (2016-2027)
Figure 68. Latin America Pentobarbital Sodium Injection Sales Market Share by Application (2016-2027)
Figure 69. Latin America Pentobarbital Sodium Injection Revenue Market Share by Application (2016-2027)
Figure 70. Latin America Pentobarbital Sodium Injection Sales Share by Country (2016-2027)
Figure 71. Latin America Pentobarbital Sodium Injection Revenue Share by Country (2016-2027)
Figure 72. Mexico Pentobarbital Sodium Injection Revenue (2016-2027) & (US$ Million)
Figure 73. Brazil Pentobarbital Sodium Injection Revenue (2016-2027) & (US$ Million)
Figure 74. Argentina Pentobarbital Sodium Injection Revenue (2016-2027) & (US$ Million)
Figure 75. Middle East and Africa Pentobarbital Sodium Injection Sales Market Share by Dosage Form & Strength Type (2016-2027)
Figure 76. Middle East and Africa Pentobarbital Sodium Injection Revenue Market Share by Dosage Form & Strength Type (2016-2027)
Figure 77. Middle East and Africa Pentobarbital Sodium Injection Sales Market Share by Application (2016-2027)
Figure 78. Middle East and Africa Pentobarbital Sodium Injection Revenue Market Share by Application (2016-2027)
Figure 79. Middle East and Africa Pentobarbital Sodium Injection Sales Share by Country (2016-2027)
Figure 80. Middle East and Africa Pentobarbital Sodium Injection Revenue Share by Country (2016-2027)
Figure 81. Turkey Pentobarbital Sodium Injection Revenue (2016-2027) & (US$ Million)
Figure 82. Saudi Arabia Pentobarbital Sodium Injection Revenue (2016-2027) & (US$ Million)
Figure 83. UAE Pentobarbital Sodium Injection Revenue (2016-2027) & (US$ Million)
Figure 84. Pentobarbital Sodium Injection Value Chain
Figure 85. Pentobarbital Sodium Injection Production Process
Figure 86. Channels of Distribution
Figure 87. Distributors Profiles
Figure 88. Bottom-up and Top-down Approaches for This Report
Figure 89. Data Triangulation
Figure 90. Key Executives Interviewed
ミトキサントロン注射のグローバル市場インサイト・予測（～2027年） Mitoxantrone Injection is a chemotherapy drug. It targets fast dividing cells, like cancer cells, and causes these cells to die. This medicine is used to treat acute nonlymphocytic leukemia (ANLL) and advanced prostate cancer. It is also used to treat certain types of multiple sclerosis. Market Anal…- メトロニダゾール注射のグローバル市場インサイト・予測（～2027年） Metronidazole Injection is a sterile, parenteral dosage form of metronidazole in water. Metronidazole is classified as a synthetic antibacterial and antiprotozoal agent and is administered by the intravenous route. To reduce the development of drug-resistant bacteria and maintain the effectiveness o…
- テトラデシル硫酸ナトリウム注射のグローバル市場インサイト・予測（～2027年） Sodium Tetradecyl Sulfate Injection is a sclerosing agent. It works by increasing the formation of blood clots and scar tissue inside certain types of veins. This helps decrease dilation of enlarged veins. Market Analysis and Insights: Global Sodium Tetradecyl Sulfate Injection Market The global Sod…
- ニケタミド注射のグローバル市場インサイト・予測（～2027年） Nikezamei injection is indicated for central respiratory depression and respiratory depression caused by various reasons. Market Analysis and Insights: Global Nikethamide Injection Market The global Nikethamide Injection market is valued at US$ million in 2020. The market size will reach US$ million…
- ピペラシリンナトリウムAPIのグローバル市場インサイト・予測（～2027年） Piperacillin Sodium is the sodium salt of piperacillin, a broad-spectrum semisynthetic, ampicillin-derived ureidopenicillin antibiotic with bactericidal activity. Piperacillin binds to and inactivates penicillin-binding proteins (PBPs), enzymes located on the inner membrane of the bacterial cell wal…